Clinical Trial Update: To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension. [Phase 4]

View source ↗

Summary

Phase 4 trial updating the efficacy and safety of oral sildenafil for pulmonary arterial hypertension, terminated with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: TERMINATED | Results posted: 2011-05-17